Global Epilepsy Market Size to grow USD 4.7 Billion by 2030 | CAGR of 8.35%: Spherical Insights
20 mars 2023 16h00 HE
|
SPHERICAL INSIGHTS LLP
New York, United States, March 20, 2023 (GLOBE NEWSWIRE) -- Global Epilepsy Market worth $4.70 Billion by 2030 According to a research report published by Spherical Insights &...
QSAM Biosciences to Provide Updates on its Clinical Trial at the Emerging Growth Conference on Wednesday, March 22, 2023
20 mars 2023 08h30 HE
|
QSAM Biosciences Inc.
QSAM invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. Austin, TX, March 20,...
Lupus Nephritis Treatment Market is expected to accumulate a value of US$ 5.67 Billion by registering a CAGR of 11% in the forecast period 2023 to 2033 | Future Market Insights, Inc.
17 mars 2023 05h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, March 17, 2023 (GLOBE NEWSWIRE) -- During the forecast period 2023 to 2033, the Lupus Nephritis Treatment Market is expected to grow at a value of 11% CAGR, according to Future Market...
Interim review of proprietary PsiGAD clinical trial data indicates no safety concerns and projects a statistically significant benefit for the psilocybin arm versus the placebo arm in those participants who have completed the treatment
15 mars 2023 07h30 HE
|
Incannex Healthcare
Highlights: Interim analysis of study data to date indicates that there is a greater than 85% chance (>85%, alpha error probability 0.05) of the study showing a statistically significant benefit...
Huntington’s Disease Treatment Market is expected to grow from USD 365 million in 2022 to USD 1,517 million by 2030 : GreyViews
06 févr. 2023 16h00 HE
|
GreyViews
Pune India, Feb. 06, 2023 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle...
Independent data review commences for Phase 2 trial of psilocybin-assisted psychotherapy for anxiety
18 janv. 2023 08h00 HE
|
Incannex Healthcare
MELBOURNE, Australia, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’), a pharmaceutical company developing proprietary...
Glioblastoma Multiforme Treatment Market Is Estimated to Grow at CAGR Of 8.1%, 2022-2029 | Latest Industry Coverage by Douglas Insights
11 janv. 2023 03h52 HE
|
Douglas Insights
Isle of Man, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Douglas Insights has added the Global Glioblastoma Multiforme treatment market research to its growing market reports. Douglas Insightsinsights tries...
QSAM Biosciences Provides 2022 Update and 2023 Milestones to Shareholders
10 janv. 2023 07h00 HE
|
QSAM Biosciences Inc.
AUSTIN, Texas, Jan. 10, 2023 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam®),...
Trimera Health Offers Medical Marijuana to Treat Patients With PTSD
05 janv. 2023 14h00 HE
|
Trimera Health
HOUSTON, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Trimera Health is offering psychiatric treatment for post-traumatic stress disorder (PTSD) patients using marijuana, or cannabis, and building an uplifting...
Canadian Brain Cancer Patients Treated Unequally: Brain Cancer Canada
26 oct. 2022 08h30 HE
|
Brain Cancer Canada
TORONTO, Oct. 26, 2022 (GLOBE NEWSWIRE) -- For Canadians diagnosed with brain cancer, where they live determines how much access they have to treatment, according to new research by the charity...